These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
311 related items for PubMed ID: 19502811
1. Co-suppression of MDR1 (multidrug resistance 1) and GCS (glucosylceramide synthase) restores sensitivity to multidrug resistance breast cancer cells by RNA interference (RNAi). Zhang X, Li J, Qiu Z, Gao P, Wu X, Zhou G. Cancer Biol Ther; 2009 Jun; 8(12):1117-21. PubMed ID: 19502811 [Abstract] [Full Text] [Related]
2. MDR1 (multidrug resistence 1) can regulate GCS (glucosylceramide synthase) in breast cancer cells. Zhang X, Wu X, Li J, Sun Y, Gao P, Zhang C, Zhang H, Zhou G. J Surg Oncol; 2011 Oct; 104(5):466-71. PubMed ID: 21538359 [Abstract] [Full Text] [Related]
3. The effect of glucosylceramide synthase on P-glycoprotein function in K562/AO2 leukemia drug-resistance cell line. Zhang YY, Xie KM, Yang GQ, Mu HJ, Yin Y, Zhang B, Xie P. Int J Hematol; 2011 Mar; 93(3):361-367. PubMed ID: 21380926 [Abstract] [Full Text] [Related]
4. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery. Gu J, Fang X, Hao J, Sha X. Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500 [Abstract] [Full Text] [Related]
6. Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance. Liu YY, Han TY, Giuliano AE, Hansen N, Cabot MC. J Biol Chem; 2000 Mar 10; 275(10):7138-43. PubMed ID: 10702281 [Abstract] [Full Text] [Related]
7. [Construction of glucosylceramide synthase-specific siRNA expression vector and its efficiency in reversal of drug resistance in breast carcinoma cells]. Sun YL, Zhou GY, Li KN, Li WT, Song XR, Gao P. Zhonghua Yi Xue Za Zhi; 2005 Mar 02; 85(8):518-21. PubMed ID: 15949329 [Abstract] [Full Text] [Related]
8. Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells. Liu F, Liu S, He S, Xie Z, Zu X, Jiang Y. Oncol Rep; 2010 May 02; 23(5):1469-75. PubMed ID: 20372866 [Abstract] [Full Text] [Related]
9. Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs. Gouazé V, Liu YY, Prickett CS, Yu JY, Giuliano AE, Cabot MC. Cancer Res; 2005 May 01; 65(9):3861-7. PubMed ID: 15867385 [Abstract] [Full Text] [Related]
10. Suppression of glucosylceramide synthase by RNA interference reverses multidrug resistance in human breast cancer cells. Sun YL, Zhou GY, Li KN, Gao P, Zhang QH, Zhen JH, Bai YH, Zhang XF. Neoplasma; 2006 May 01; 53(1):1-8. PubMed ID: 16416005 [Abstract] [Full Text] [Related]
11. Loperamide, an FDA-approved antidiarrhea drug, effectively reverses the resistance of multidrug resistant MCF-7/MDR1 human breast cancer cells to doxorubicin-induced cytotoxicity. Zhou Y, Sridhar R, Shan L, Sha W, Gu X, Sukumar S. Cancer Invest; 2012 Feb 01; 30(2):119-25. PubMed ID: 22250587 [Abstract] [Full Text] [Related]
12. Functional study of the novel multidrug resistance gene HA117 and its comparison to multidrug resistance gene 1. Zhao L, Jin X, Xu Y, Guo Y, Liang R, Guo Z, Chen T, Sun Y, Ding X. J Exp Clin Cancer Res; 2010 Jul 19; 29(1):98. PubMed ID: 20642825 [Abstract] [Full Text] [Related]
13. GCS overexpression is associated with multidrug resistance of human HCT-8 colon cancer cells. Song M, Zang W, Zhang B, Cao J, Yang G. J Exp Clin Cancer Res; 2012 Mar 16; 31(1):23. PubMed ID: 22424291 [Abstract] [Full Text] [Related]
14. Reversing multidrug resistance by RNA interference through the suppression of MDR1 gene in human hepatoma cells. Chen XP, Wang Q, Guan J, Huang ZY, Zhang WG, Zhang BX. World J Gastroenterol; 2006 Jun 07; 12(21):3332-7. PubMed ID: 16733848 [Abstract] [Full Text] [Related]
15. Overexpression of glucosylceramide synthase and P-glycoprotein in cancer cells selected for resistance to natural product chemotherapy. Gouazé V, Yu JY, Bleicher RJ, Han TY, Liu YY, Wang H, Gottesman MM, Bitterman A, Giuliano AE, Cabot MC. Mol Cancer Ther; 2004 May 07; 3(5):633-9. PubMed ID: 15141021 [Abstract] [Full Text] [Related]
16. Reversal of adriamycin resistance in human mammary cancer cells by small interfering RNA of MDR1 and MDR3 genes. Xiao L, Gao R, Lu S, Ren L, Wang Z. J Huazhong Univ Sci Technolog Med Sci; 2006 May 07; 26(6):735-7. PubMed ID: 17357504 [Abstract] [Full Text] [Related]
17. [Reversing multidrug resistance in breast cancer cell line MCF-7/ADR by small interfering RNA]. Li CB, Zhang F, Shi YR, Wei XY, Yang Y, Niu RF. Ai Zheng; 2004 Dec 07; 23(12):1605-10. PubMed ID: 15601546 [Abstract] [Full Text] [Related]
18. [Synergic effect of Na(+)-K(+) ATPaseB1 and adriamycin on inhibition of cell proliferation and reversal of drug resistance in breast cancer MCF-7 cells]. Qi YY, Liu K, Zhang J, Li K, Ren JJ, Lin P. Ai Zheng; 2009 Aug 07; 28(8):861-7. PubMed ID: 19664334 [Abstract] [Full Text] [Related]
19. Ceramide and glucosylceramide upregulate expression of the multidrug resistance gene MDR1 in cancer cells. Gouazé-Andersson V, Yu JY, Kreitenberg AJ, Bielawska A, Giuliano AE, Cabot MC. Biochim Biophys Acta; 2007 Dec 07; 1771(12):1407-17. PubMed ID: 18035065 [Abstract] [Full Text] [Related]
20. Reversing multidrug-resistant by RNA interference through silencing MDR1 gene in human hepatocellular carcinoma cells subline Bel-7402/ADM. Sheng L, Xiong M, Li C, Meng X. Pathol Oncol Res; 2014 Jul 07; 20(3):541-8. PubMed ID: 24327315 [Abstract] [Full Text] [Related] Page: [Next] [New Search]